DE3571976D1 - Pyrazole compounds - Google Patents

Pyrazole compounds

Info

Publication number
DE3571976D1
DE3571976D1 DE8585304237T DE3571976T DE3571976D1 DE 3571976 D1 DE3571976 D1 DE 3571976D1 DE 8585304237 T DE8585304237 T DE 8585304237T DE 3571976 T DE3571976 T DE 3571976T DE 3571976 D1 DE3571976 D1 DE 3571976D1
Authority
DE
Germany
Prior art keywords
pyrazole compounds
useful
prevent
pyrazole
compounds inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585304237T
Other languages
English (en)
Inventor
Kenneth Steven Hirsch
Charles David Jones
Harold Mellon Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3571976D1 publication Critical patent/DE3571976D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8585304237T 1984-06-18 1985-06-14 Pyrazole compounds Expired DE3571976D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,598 US4609666A (en) 1984-06-18 1984-06-18 Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles

Publications (1)

Publication Number Publication Date
DE3571976D1 true DE3571976D1 (de) 1989-09-07

Family

ID=24490838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585304237T Expired DE3571976D1 (de) 1984-06-18 1985-06-14 Pyrazole compounds

Country Status (6)

Country Link
US (1) US4609666A (de)
EP (1) EP0165782B1 (de)
JP (1) JPH0625132B2 (de)
AT (1) ATE45148T1 (de)
CA (1) CA1266665A (de)
DE (1) DE3571976D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
GB8614712D0 (en) * 1986-06-17 1986-07-23 Ici Plc Heterocyclic compounds
US5039677A (en) * 1987-06-01 1991-08-13 Janssen Pharmaceutica N.V. 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US4943574A (en) * 1987-06-01 1990-07-24 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
DE3926365A1 (de) * 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
TW210334B (de) * 1990-12-12 1993-08-01 Ciba Geigy Ag
RO114129B1 (ro) * 1991-09-02 1999-01-29 Yamanouchi Pharmaceutical Co., Ltd. Derivaţi aminici terţiari substituiţi cu triazolil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123615A (en) * 1964-03-03 Oxyphenyl
US3155666A (en) * 1963-07-18 1964-11-03 Searle & Co 1-dialkylaminoalkyl-5-diphenylmethyl-1h-tetrazoles and related compounds
BR6915465D0 (pt) * 1969-03-07 1973-01-04 Bayer Ag Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica
BE756663A (fr) * 1969-09-27 1971-03-25 Bayer Ag Composition destinee a la regulation de la croissance des vegetaux
DE2009020C3 (de) * 1970-02-26 1979-09-13 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen
US3764690A (en) * 1972-03-03 1973-10-09 Bayer Ag Substituted n-benzylimidazoles as antimycotic agents
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3129193A1 (de) * 1981-07-24 1983-02-03 Hoechst Ag, 6000 Frankfurt Azolderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel

Also Published As

Publication number Publication date
JPH0625132B2 (ja) 1994-04-06
CA1266665A (en) 1990-03-13
JPS6112668A (ja) 1986-01-21
ATE45148T1 (de) 1989-08-15
EP0165782A1 (de) 1985-12-27
EP0165782B1 (de) 1989-08-02
US4609666A (en) 1986-09-02

Similar Documents

Publication Publication Date Title
NL930005I2 (nl) 17 Beta-gesubstitueerde-4-aza-5alfa-androstenonen en gebruik ervan als inhibitoren van 5alfa-reduct ase.
DK169685A (da) Aktibakterielle midler
DE3582894D1 (de) Hautbehandlungsmittel.
ATE58900T1 (de) Diaryldiazolylmethane.
IT8122595A0 (it) Procedimento per il trattamento di lisato di limulo e reagente contenente il lisato trattato.
NO852326L (no) Fremgangsmaate ved behandling av ildfaste gjenstander.
ES542763A0 (es) Procedimiento para preparar imidazoles y triazoles sustituidos de efectos fungicidas.
DE3477786D1 (de) Fungicidal imidazoles and triazoles
DE3571976D1 (de) Pyrazole compounds
ATE40822T1 (de) Aromatase-hemmende 1,2,3-triazol-1-yl-, tetrazol- 1-yl- und tetrazol-2-yl-verbindungen.
DE3885913D1 (de) Aufbereitung von Alkoxysilanen.
DK325285A (da) Behandlingsmetode
DE3574375D1 (de) Isoxazole and isothiazole derivatives
ATE109150T1 (de) Mono- und diepoxid-derivate von ll-f28249- verbindungen.
DK135486D0 (da) Efterbehandlet prostetisk organ
RO91593A (ro) Compozitie fungicida solida
BR8102412A (pt) Composicoes fungicidas e processo de obtencao da mesma
DK548385D0 (da) Stabiliserede desinfektionsmiddelkoncentrater
DK162779C (da) Indretning og fremgangsmaade til antikorrosionsbehandling
IT1211333B (it) Procedimento e composizione per il candeggio di biancheria
FR2619119B1 (fr) Cyanines
DE3883082D1 (de) Phenol-thioether als inhibitoren von 5-lipoxygenase.
NO166114C (no) Primaeravfjaering for skinnekjoeretoey.
DE3673072D1 (de) Behandlung von lignocellulosematerialien.
NO862795L (no) Anordning til bruk ved stangfiske.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee